Renal cell carcinoma: a priority malignancy for development and study of novel therapies.

Sorry, there's nothing here.

Statistics

0102030'04'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

52 Citations

Semantic Scholar estimates that this publication has 52 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Motzer2003RenalCC, title={Renal cell carcinoma: a priority malignancy for development and study of novel therapies.}, author={Robert John Motzer}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2003}, volume={21 7}, pages={1193-4} }